Journal Menu
► ▼ Journal Menu-
- Cancers Home
- Aims & Scope
- Editorial Board
- Reviewer Board
- Topical Advisory Panel
- Early Career Editorial Board
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Society Collaborations
- Conferences
- Editorial Office
Journal Browser
► ▼ Journal BrowserNeed Help?
Announcements
7 August 2024
MDPI Insights: The CEO's Letter #14 - New Headquarters, Marketing, Poland
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts

MDPI Moves to New Headquarters in Basel, Switzerland

I am excited to share that MDPI has moved to a new state-of-the-art office space in Basel, Switzerland. This move consolidates our operations by bringing together our two previously separated Basel offices into one central location.
We are always growing our talent pool and encourage you to view our Careers Page for the positions available in Basel and across our offices.
New Address: Grosspeteranlage 5, CH-4052 Basel, Switzerland
Effective Date: 1 July 2024
This new chapter in our company’s journey is designed to continue our mission of positioning MDPI as a leader in Open Access (OA) publishing, highlighting our commitment to making scholarly research accessible to everyone.

Boasting modern amenities, improved meeting and event spaces designed to support our growing needs, the new location provides a more collaborative and efficient working environment for our employees. The location offers convenient accessibility to public transportation and is situated near the Basel SBB railway station, with a variety of nearby services and amenities.
In fact, I can see the trains right outside of my window as I write these lines!
This move marks an exciting milestone in MDPI’s development, and I am confident that the new headquarters will serve as an inspiring and productive space for everyone. We also very much look forward to welcoming visitors here. You can read more about MDPI's history here.
“This new chapter continues our mission of positioning MDPI as a leader in OA publishing”
For Those New to MDPI
A pioneer in scholarly, Open Access publishing, MDPI has supported academic communities since 1996. MDPI is leading the transition to Open Science by making a greater proportion of the research conducted worldwide free and accessible to everyone. To date, over 3.5 million researchers have entrusted MDPI with publishing their scientific discoveries. MDPI’s editorial process is bolstered by a network of dedicated reviewers, a team of 6,000 professional, well-trained staff members, and an in-house article submission platform designed to ensure efficient processes within its 440 fully Open Access titles. MDPI supports more than 800 academic institutions worldwide, helping them adhere to national mandates while facilitating authors’ publication in fully compliant (CC BY) Open Access journals.
Impactful Research

New and Emerging MDPI Journals Making an Immediate Impact
Unpacking some of the Impact Factor updates from the June CEO Letter, I wanted to dive a little deeper into the 137 MDPI journals which received Impact Factor for the first time.
Academic authors highly value efficient publishing processes, robust editorial support, and the opportunity to publish in high-impact journals. We are proud that our newly launched journals typically achieve coverage in the Emerging Sources Citation Index (ESCI) of the Web of Science within just a few years, with a median time of only three years from release to inclusion.
As part of our commitment to advancing academic research and providing high-quality OA publishing, we actively seek new research areas to expand our portfolio of journals. We have a proven track record of successfully establishing new journals.
Our dedicated teams excel in fostering dynamic editorial boards and working closely with Editors-in-Chief (EiC) to define the precise scope and focus of each new journal. Our expertise extends to collaborating with indexing services, ensuring that our journals comply with best practices and are indexed promptly in all relevant databases.
Emerging Titles Ranked for the First Time
Our commitment to excellence is reflected in the annual impact metrics released this past June. The latest edition of the Journal Citation Reports (JCR) showcases the integration of journals from the ESCI in the new unified category rankings, providing a simplified and more complete view of all journals within each subject category, including newly established titles.
Out of 137 new and developing MDPI journals ranked in the 2024 release, 79 are in the top half (Q1 or Q2) of their categories. Here is a breakdown of the number of MDPI’s ESCI-indexed journals by quartile in the JCR:
| Quartile | No. of journals |
| Q1 | 17 (12.4%) |
| Q2 | 62 (45.3%) |
| Q3 | 43 (31.4%) |
| Q4 | 15 (10.9%) |
| Not ranked (humanities-related journals) | 2 |
These rankings highlight our success in rapidly establishing high-impact new journals. Among those that made it directly into the top 25% of their category are the International Journal of Neonatal Screening, Journal of Xenobiotics, Polysaccharides, Smart Cities, and thirteen other journals.
You can browse MDPI journals by Indexing. Simply visit our Journals page and select from the list of Indexing bodies in the top left-hand corner.
Inside MDPI

MDPI Corporate Marketing Strategy and Team Meeting 2024
In July, I hosted the annual Corporate Marketing strategy and team-building activity with 15 of our team members.

The aim was to align the Corporate Marketing strategy with MDPI's goal of becoming the world's most trusted OA publisher. While we provide a high-level publishing experience for our authors, as seen from our surveys, we need to keep building on our transparent and open communication to foster trust within the scholarly community and continue enhancing our reputation.
The Corporate Marketing team plays an important role as the mouthpiece for all our major activities within MDPI, especially those that model what it means to be a trusted partner. The purpose of the strategy meeting was to develop a feeling of trust in one another and an understanding of how to inspire trust in the stakeholders with whom we interact.
“We need to keep building on our transparent and open communication to foster trust within the scholarly community”

We conducted a set of activities to facilitate that sense of mutual trust and trustworthiness. Examples of some activities we worked on during this strategy-building event include:
- Exploring what trust means
- ‘Letter to self’
- ‘The brand I most trust’
- Most Trusted Academic Publisher
- ‘The brand I would like MDPI to become’
- ‘The 2029 MDPI Annual Report’
- Voice of Customer and Share of Voice – survey/data update on MDPI Brand Experience and Brand Perception
- Integrate Trust-Based Objective into Marketing Plan
- ‘Becoming the MDPI experience’
- ‘Trusting the next steps’
While two days is not enough to finalize a marketing strategy, it is sufficient to get everyone who attended into the mindset of the direction in which we are working. From here, we will develop a program with next steps on main projects, update communications, and collaborate with team leads to incorporate this approach into our work going forward.
As a marketing team, we can communicate our messages, but trust has to be built at every touchpoint in the stakeholder journey. Just talking about it isn’t enough. We need to be about it. That’s a role each of us plays, from editorial to IT, from marketing to HR. We must build trust from the inside out. It starts with each manager and resonates out via every team member.
As a company, our goal is to give all stakeholders with whom we interact – whether internal or external – the experience of working with an organization it can trust.
Coming Together for Science

MDPI in Poland: Krakow Office
In July, I had the pleasure of visiting our Krakow office, following my recent trip to Warsaw to meet with the Polish Ministry of Science and Higher Education.

During these visits, I prioritized meeting with our Office Manager, Editorial Director, Group Leads, and members from various teams, including editorial, production, marketing, and journal relationship specialists, to understand their roles and current challenges. Instead of a formal presentation, I opted for an open discussion, sharing updates from headquarters to engage with colleagues in a more personal way.
Our Krakow office has many things to be proud of, including a large number of PhD colleagues (over a third of its staff holds a PhD degree). Krakow provides an opportunity for expanding beyond the 100 colleagues we currently have, by adding new hires in departments including editorial, production and marketing, among others.
About our Krakow office
- Opened in 2020
- 99 staff members as at 1 August 2024
- Main Departments include Editorial, Production, English Department, JRS, PR
Our Krakow office participates in international conferences, conducts author trainings and scholar visits, and engages in local market outreach. The office is also a member of the Polish Chamber of Commerce for High Technology (IZTECH) and is working on expanding its local engagement.
Krakow is the second-largest city in Poland, with a population of about 800,000. It also has a large student population of around 128,000, with seven universities. This means that roughly one in every eight residents is a student.
Poland and MDPI

Poland is a crucial market for MDPI. From 2020 to June 2024, Poland ranked 7th in submissions and 5th in publications for MDPI research articles. As at 31 July 2024, Poland ranks 7th in total MDPI publications, with approximately 70,000 research papers.
Between 2020 and June 2024, 61,500 authors from Poland published with MDPI. As at 30 June 2024, there are 1,205 active Editorial Board Members (EBMs) from Poland, with 661 EBMs (55% of the total) having an H-index over 25.
We also have four Editors-in-Chief (EiC) from Poland leading our journals: Coatings, Venereology, Advances in Respiratory Medicine, and Limnological Review, along with six Section EiC.
In 2023, we received approximately 21,000 submissions from Polish-affiliated authors, of which 12,032 were published.
“Poland is a crucial market for MDPI”
Meeting with Ministry of Education

On 22 July, we visited Warsaw to meet with the Polish Ministry of Science and Higher Education.
We were pleased to learn that they are strong supporters of the OA publishing model and value MDPI’s approach to the peer-review process, including our high ethical standards for quality control.
In 2023 Polish authors predominantly published their papers in OA, with MDPI holding the largest market share in OA publications within the country.
Our commitment to collaborating with Polish institutions is evident through our 33 Institutional Open Access Program (IOAP) agreements with prestigious institutions such as the University of Warsaw, the University of Wroclaw, the Jagiellonian University, and Gdańsk University of Technology. Through IOAP discounts, a healthy waiver rate, and our peer-review voucher system, we provide the Polish scholarly community with significant savings in OA publishing. The Minister greatly appreciated these efforts and our commitment to offsetting some of the APC costs.
We discussed industry concerns about the threat of papermills and presented the preventive measures MDPI has in place to mitigate this risk and uphold high ethical standards. We informed them of our commitment to combating papermills, including our involvement with United2Act and the STM Research Integrity Hub, as well as our efforts to expand our research integrity team and explore proactive measures.
Closing Thoughts

MDPI Thought Leadership Op-ed on Open Access is Now Live on Politico
I am pleased to share that our thought leadership Op-ed piece on Open Access (OA) is now live on Politico. This is a nice push for continued influence and support of OA among policymakers and industry leaders.
Why Politico?
Politico's reputation as a highly credible and influential news platform makes it an important venue to reach key opinion leaders (KOL) from academia, policymakers, and thought leaders from many industries. This visibility helps promote the OA philosophy.
Open Access: A Moral Imperative for Progress
In this piece, I discuss the necessity of making scientific research freely available to all. I argue that publicly funded research should be publicly accessible, highlighting how OA democratizes scientific knowledge, accelerates research availability, and fosters collaboration.
“Open Access is a fundamental right for all citizens”
Democratizing scientific communication
The impulse to democratize scientific communication is nothing new. OA may seem like a recent innovation, but its principles have historical roots traceable to Europe in the 15th century. Just as the printing revolution accelerated the dissemination of new ideas, OA publishing unlocks new scientific insights that would otherwise only be accessible to a few.
Benefits for scholars: amplifying impact through Open Access
Authors publishing in an OA journal can expect more citations of their work, increasing its potential impact. Research findings that are freely available are more likely to be cited than those hidden behind a paywall. Freedom of access greatly increases the potential audience for each paper, fostering a sense of community among researchers worldwide. Heightened visibility can attract prospective collaborators and employers for young scientists. At MDPI, we believe that all these factors can only accelerate the advance of science. Additionally, authors retain copyright in their work instead of signing it away, permitting broader dissemination under Creative Commons licenses and increasing its capacity for impact.
The moral imperative
OA is not just a matter of scientific policy; it is a fundamental right for all citizens and a prerequisite for a brighter, more informed future. Publicly funded research should be a top priority, and I am pleased to see policy moving in this direction. Our capacity to generate transformative scientific insights has to be democratized. The question today is no longer whether we can afford to embrace OA; rather, it is whether we can afford not to.
Chief Executive Officer
MDPI AG
2 August 2024
MDPI Romania Author Training Sessions in May
In May, MDPI Romania held three author training sessions – one endorsing an external event and two stand-alone sessions.
The National Session of Scientific Student Communications took place at Technical University Cluj on 17 and 18 May 2024. MDPI Romania sponsored this event and contributed an author training session on the production of research papers and case study analyses. JRS Norbert Kiss gave a presentation called The World of Open Access to explain different open access publishing models and the benefits of open access publishing. His presentation highlighted the impact of open access publishing on scientific progress and innovation.

On 29 May 2024, MDPI Romania hosted an author training session for Ph.D. students, early career researchers, and professors at the Carol Davila University of Medicine and Pharmacy. In collaboration with Prof. Andreea Arsene, JRS Ioana Paunescu prepared two presentations: The Steps of the Publishing Process and Elaboration of a Peer Review Report. In her first presentation, she delved into MDPI’s history and mission, MDPI’s editorial process, and MDPI journals of various scopes that are accepting submissions. Her second presentation outlined the types of peer review, the contents of a peer review report by an MDPI reviewer, and the responsibilities of an MDPI reviewer.

MDPI Romania also hosted an author training session at the Iasi University of Life Sciences on 29 May 2024. JRSs Laurentiu Preda and Cosmin Artan gave four presentations: Efficient Writing of an ISI-Indexed Scientific Article, Benefits of Publishing in the Open Access Model, Various Methods of Open Access Publishing, and MDPI Guide for the Article Review Process. The first three presentations offered guidance on how to improve academic writing, the fourth focused on how to write peer review reports. A highly interactive discussion followed the presentations, during which the JRSs provided extensive answers to attendees’ questions.

MDPI is grateful for all the attendees, speakers, and organizers involved in these events. Through their enthusiasm and dedication, these events were great successes.
1 August 2024
Meet Us at the 2024 CAMO Annual Scientific Meeting, 24–26 October 2024, Ottawa, ON, Canada
Conference: 2024 CAMO Annual Scientific Meeting
Date: 24–26 October 2024
Location: Ottawa, ON, Canada
The Canadian Association of Medical Oncologists (CAMO) is a national specialty society of the Royal College of Physicians and Surgeons of Canada. Their mission is to contribute to cancer control, through research, education, and clinical practice in prevention, screening, diagnosis, treatment, supportive care, palliative care, and rehabilitation. The Association is committed to achieving and maintaining, among its members, excellence in clinical and scholarly activity, within a culture of compassion and respect for human dignity. CAMO Annual Scientific Meetings have been held since 2014.
The following MDPI journals will be represented at the 2024 CAMO Annual Scientific Meeting:
- Current Oncology;
- Cancers;
- Life;
- Onco;
- Women;
- Journal of Personalized Medicine;
- Journal of Molecular Pathology.
Our delegates look forward to meeting you in person at the booth at the conference and answering any questions you may have. For more information regarding the conference, please visit the following link: https://camo-acom.ca/page-1549450.
26 July 2024
Cancers | Highly Cited Papers in 2023 in the Section “Pediatric Oncology”
As all of the articles published in Cancers (ISSN: 2072-6694) are open access, you have free and unlimited access to the full text of all articles. We welcome you to read our most highly cited papers published in 2023 in the Section “Pediatric Oncology”, which are listed below:
1. “Synovial Sarcoma in the Extremity: Diversity of Imaging Features for Diagnosis and Prognosis”
by Eun Byul Cho, Seul Ki Lee, Jee-Young Kim and Yuri Kim
Cancers 2023, 15(19), 4860; https://doi.org/10.3390/cancers15194860
Available online: https://www.mdpi.com/2072-6694/15/19/4860
2. “Pediatric Extra-Renal Nephroblastoma (Wilms’ Tumor): A Systematic Case-Based Review”
by Akzhol Karim, Kundyz Shaikhyzada, Nazgul Abulkhanova, Akzhunis Altyn, Bakytkali Ibraimov, Dair Nurgaliyev and Dimitri Poddighe
Cancers 2023, 15(9), 2563; https://doi.org/10.3390/cancers15092563
Available online: https://www.mdpi.com/2072-6694/15/9/2563
3. “Preclinical Models of Neuroblastoma—Current Status and Perspectives”
by Ewa Krawczyk and Joanna Kitlińska
Cancers 2023, 15(13), 3314; https://doi.org/10.3390/cancers15133314
Available online: https://www.mdpi.com/2072-6694/15/13/3314
4. “Naxitamab Combined with Granulocyte-Macrophage Colony-Stimulating Factor as Consolidation for High-Risk Neuroblastoma Patients in First Complete Remission under Compassionate Use—Updated Outcome Report”
by Jaume Mora, Alicia Castañeda, Maite Gorostegui, Amalia Varo, Sara Perez-Jaume, Margarida Simao, Juan Pablo Muñoz, Moira Garraus, Cristina Larrosa, Noelia Salvador et al.
Cancers 2023, 15(9), 2535; https://doi.org/10.3390/cancers15092535
Available online: https://www.mdpi.com/2072-6694/15/9/2535
5. “Functional Alteration in the Brain Due to Tumour Invasion in Paediatric Patients: A Systematic Review”
by Nur Shaheera Aidilla Sahrizan, Hanani Abdul Manan, Hamzaini Abdul Hamid, Jafri Malin Abdullah and Noorazrul Yahya
Cancers 2023, 15(7), 2168; https://doi.org/10.3390/cancers15072168
Available online: https://www.mdpi.com/2072-6694/15/7/2168
6. “Effect and Tolerance of N5 and N6 Chemotherapy Cycles in Combination with Dinutuximab Beta in Relapsed High-Risk Neuroblastoma Patients Who Failed at Least One Second-Line Therapy”
by Holger N. Lode, Ruth Ladenstein, Sascha Troschke-Meurer, Linda Struppe, Nikolai Siebert, Maxi Zumpe, Karoline Ehlert, Stefanie Huber, Evgenia Glogova, Patrick Hundsdoerfer et al.
Cancers 2023, 15(13), 3364; https://doi.org/10.3390/cancers15133364
Available online: https://www.mdpi.com/2072-6694/15/13/3364
7. “Risk-Stratified Therapy for Pediatric Acute Myeloid Leukemia”
by Daisuke Tomizawa and Shin-Ichi Tsujimoto
Cancers 2023, 15(16), 4171; https://doi.org/10.3390/cancers15164171
Available online: https://www.mdpi.com/2072-6694/15/16/4171
8. “Biological Role and Clinical Implications of MYOD1L122R Mutation in Rhabdomyosarcoma”
by Daniela Di Carlo, Julia Chisholm, Anna Kelsey, Rita Alaggio, Gianni Bisogno, Veronique Minard-Colin, Meriel Jenney, Raquel Dávila Fajardo, Johannes H. M. Merks, Janet M. Shipley et al.
Cancers 2023, 15(6), 1644; https://doi.org/10.3390/cancers15061644
Available online: https://www.mdpi.com/2072-6694/15/6/1644
9. “Ferroptosis Inducers Kill Mesenchymal Stem Cells Affected by Neuroblastoma”
by Xiangze Li, Qi Wang, Chencheng Xu, Lei Zhang, Jiquan Zhou, Jingchun Lv, Min Xu and Dapeng Jiang
Cancers 2023, 15(4), 1301; https://doi.org/10.3390/cancers15041301
Available online: https://www.mdpi.com/2072-6694/15/4/1301
10. “Marine Cyanobacterial Peptides in Neuroblastoma: Search for Better Therapeutic Options”
by Salman Ahmed, Waqas Alam, Michael Aschner, Rosanna Filosa, Wai San Cheang, Philippe Jeandet, Luciano Saso and Haroon Khan
Cancers 2023, 15(9), 2515; https://doi.org/10.3390/cancers15092515
Available online: https://www.mdpi.com/2072-6694/15/9/2515
11. “Dynamic Changes in Microvascular Density Can Predict Viable and Non-Viable Areas in High-Risk Neuroblastoma”
by Laura Privitera, Layla Musleh, Irene Paraboschi, Olumide Ogunlade, Olumide Ogunbiyi, J. Ciaran Hutchinson, Neil Sebire, Paul Beard and Stefano Giuliani
Cancers 2023, 15(3), 917; https://doi.org/10.3390/cancers15030917
Available online: https://www.mdpi.com/2072-6694/15/3/917
by Piotr Pawłowski, Karolina Joanna Ziętara, Justyna Michalczyk, Magdalena Fryze, Anna Buchacz, Agnieszka Zaucha-Prażmo, Joanna Zawitkowska, Anna Torres and Marzena Samardakiewicz
Cancers 2023, 15(17), 4393; https://doi.org/10.3390/cancers15174393
Available online: https://www.mdpi.com/2072-6694/15/17/4393
13. “Intracranial Germinoma—Association between Delayed Diagnosis, Altered Clinical Manifestations, and Prognosis”
by Iwona Jabłońska, Marcin Goławski, Elżbieta Nowicka, Katarzyna Drosik-Rutowicz, Anna Trybus, Rafał Tarnawski and Marcin Miszczyk
Cancers 2023, 15(10), 2789; https://doi.org/10.3390/cancers15102789
Available online: https://www.mdpi.com/2072-6694/15/10/2789
14. “DICER1 Syndrome: A Multicenter Surgical Experience and Systematic Review”
by Claudio Spinelli, Marco Ghionzoli, Linda Idrissi Sahli, Carla Guglielmo, Silvia Frascella, Silvia Romano, Carlo Ferrari, Fabrizio Gennari, Giovanni Conzo, Riccardo Morganti et al.
Cancers 2023, 15(14), 3681; https://doi.org/10.3390/cancers15143681
Available online: https://www.mdpi.com/2072-6694/15/14/3681
15. “PRMT5 as a Potential Therapeutic Target in MYC-Amplified Medulloblastoma”
by Devendra Kumar, Stuti Jain, Don W. Coulter, Shantaram S. Joshi and Nagendra K. Chaturvedi
Cancers 2023, 15(24), 5855; https://doi.org/10.3390/cancers15245855
Available online: https://www.mdpi.com/2072-6694/15/24/5855
You are invited to view and submit relevant papers to the journal Cancers.
Cancers Editorial Office
23 July 2024
Cancers | Highly Cited Papers in 2023
As all of the articles published in Cancers (ISSN: 2072-6694) are open access, you have free and unlimited access to the full text of all articles. We welcome you to read our most highly cited papers published in 2023. The list of relevant papers can be seen below.
1. “Current Status and Future Prospects for Esophageal Cancer”
by Mahdi Sheikh, Gholamreza Roshandel, Valerie McCormack and Reza Malekzadeh
Cancers 2023, 15(3), 765; https://doi.org/10.3390/cancers15030765
Available online: https://www.mdpi.com/2072-6694/15/3/765
2. “Mechanisms of ADC Toxicity and Strategies to Increase ADC Tolerability”
by Toan D. Nguyen, Brandon M. Bordeau and Joseph P. Balthasar
Cancers 2023, 15(3), 713; https://doi.org/10.3390/cancers15030713
Available online: https://www.mdpi.com/2072-6694/15/3/713
3. “What Is Known about Breast Cancer in Young Women?”
by Jie Wei Zhu, Parsa Charkhchi, Shadia Adekunte and Mohammad R. Akbari
Cancers 2023, 15(6), 1917; https://doi.org/10.3390/cancers15061917
Available online: https://www.mdpi.com/2072-6694/15/6/1917
4. “Drugs Targeting p53 Mutations with FDA Approval and in Clinical Trials”
by Shigeto Nishikawa and Tomoo Iwakuma
Cancers 2023, 15(2), 429; https://doi.org/10.3390/cancers15020429
Available online: https://www.mdpi.com/2072-6694/15/2/429
5. “Steroidal Saponins: Naturally Occurring Compounds as Inhibitors of the Hallmarks of Cancer”
by Salwa Bouabdallah, Amna Al-Maktoum and Amr Amin
Cancers 2023, 15(15), 3900; https://doi.org/10.3390/cancers15153900
Available online: https://www.mdpi.com/2072-6694/15/15/3900
6. “Hepatitis Virus and Hepatocellular Carcinoma: Recent Advances”
by Chen Shen, Xin Jiang, Mei Li and Yao Luo
Cancers 2023, 15(2), 533; https://doi.org/10.3390/cancers15020533
Available online: https://www.mdpi.com/2072-6694/15/2/533
7. “Sodium Butyrate Induces CRC Cell Ferroptosis via the CD44/SLC7A11 Pathway and Exhibits a Synergistic Therapeutic Effect with Erastin”
by Zhongbo Bian, Xiaodie Sun, Lulin Liu, Yong Qin, Qiuyu Zhang, Huahuan Liu, Lianzhi Mao and Suxia Sun
Cancers 2023, 15(2), 423; https://doi.org/10.3390/cancers15020423
Available online: https://www.mdpi.com/2072-6694/15/2/423
8. “AI-Powered Diagnosis of Skin Cancer: A Contemporary Review, Open Challenges and Future Research Directions”
by Navneet Melarkode, Kathiravan Srinivasan, Saeed Mian Qaisar and Pawel Plawiak
Cancers 2023, 15(4), 1183; https://doi.org/10.3390/cancers15041183
Available online: https://www.mdpi.com/2072-6694/15/4/1183
9. “Hyperparameter Optimizer with Deep Learning-Based Decision-Support Systems for Histopathological Breast Cancer Diagnosis”
by Marwa Obayya, Mashael S. Maashi, Nadhem Nemri, Heba Mohsen, Abdelwahed Motwakel, Azza Elneil Osman, Amani A. Alneil and Mohamed Ibrahim Alsaid
Cancers 2023, 15(3), 885; https://doi.org/10.3390/cancers15030885
Available online: https://www.mdpi.com/2072-6694/15/3/885
10. “Management of Patients Diagnosed with Endometrial Cancer: Comparison of Guidelines”
by Stefano Restaino, Chiara Paglietti, Martina Arcieri, Anna Biasioli, Monica Della Martina, Laura Mariuzzi, Claudia Andreetta, Francesca Titone, Giorgio Bogani, Diego Raimondo et al.
Cancers 2023, 15(4), 1091; https://doi.org/10.3390/cancers15041091
Available online: https://www.mdpi.com/2072-6694/15/4/1091
11. “Osimertinib Resistance: Molecular Mechanisms and Emerging Treatment Options”
by Georgia Gomatou, Nikolaos Syrigos and Elias Kotteas
Cancers 2023, 15(3), 841; https://doi.org/10.3390/cancers15030841
Available online: https://www.mdpi.com/2072-6694/15/3/841
12. “Value of Artificial Intelligence in Evaluating Lymph Node Metastases”
by Nicolò Caldonazzi, Paola Chiara Rizzo, Albino Eccher, Ilaria Girolami, Giuseppe Nicolò Fanelli, Antonio Giuseppe Naccarato, Giuseppina Bonizzi, Nicola Fusco, Giulia d’Amati, Aldo Scarpa et al.
Cancers 2023, 15(9), 2491; https://doi.org/10.3390/cancers15092491
Available online: https://www.mdpi.com/2072-6694/15/9/2491
13. “Risk of Cancer in Patients with Inflammatory Bowel Diseases and Keys for Patient Management”
by Viviana Laredo, Sandra García-Mateo, Samuel J. Martínez-Domínguez, Julia López de la Cruz, Carla J. Gargallo-Puyuelo and Fernando Gomollón
Cancers 2023, 15(3), 871; https://doi.org/10.3390/cancers15030871
Available online: https://www.mdpi.com/2072-6694/15/3/871
14. “Deep Learning for Medical Image-Based Cancer Diagnosis”
by Xiaoyan Jiang, Zuojin Hu, Shuihua Wang and Yudong Zhang
Cancers 2023, 15(14), 3608; https://doi.org/10.3390/cancers15143608
Available online: https://www.mdpi.com/2072-6694/15/14/3608
15. “The Function of NK Cells in Tumor Metastasis and NK Cell-Based Immunotherapy”
by Yanlin Yu
Cancers 2023, 15(8), 2323; https://doi.org/10.3390/cancers15082323
Available online: https://www.mdpi.com/2072-6694/15/8/2323
16. “APESTNet with Mask R-CNN for Liver Tumor Segmentation and Classification”
by Prabhu Kavin Balasubramanian, Wen-Cheng Lai, Gan Hong Seng, Kavitha C and Jeeva Selvaraj
Cancers 2023, 15(2), 330; https://doi.org/10.3390/cancers15020330
Available online: https://www.mdpi.com/2072-6694/15/2/330
17. “Fibroblasts as Turned Agents in Cancer Progression”
by Robert Wieder
Cancers 2023, 15(7), 2014; https://doi.org/10.3390/cancers15072014
Available online: https://www.mdpi.com/2072-6694/15/7/2014
18. “Sex Differences in Lung Cancer”
by Lauren May, Kathryn Shows, Patrick Nana-Sinkam, Howard Li and Joseph W. Landry
Cancers 2023, 15(12), 3111; https://doi.org/10.3390/cancers15123111
Available online: https://www.mdpi.com/2072-6694/15/12/3111
19. “hist2RNA: An Efficient Deep Learning Architecture to Predict Gene Expression from Breast Cancer Histopathology Images”
by Raktim Kumar Mondol, Ewan K. A. Millar, Peter H. Graham, Lois Browne, Arcot Sowmya and Erik Meijering
Cancers 2023, 15(9), 2569; https://doi.org/10.3390/cancers15092569
Available online: https://www.mdpi.com/2072-6694/15/9/2569
20. “Prediction of Surgical Outcome in Advanced Ovarian Cancer by Imaging and Laparoscopy: A Narrative Review”
by Patrícia Pinto, Andrea Burgetova, David Cibula, Ingfrid S. Haldorsen, Tereza Indrielle-Kelly and Daniela Fischerova
Cancers 2023, 15(6), 1904; https://doi.org/10.3390/cancers15061904
Available online: https://www.mdpi.com/2072-6694/15/6/1904
You are invited to view and submit relevant papers to the journal Cancers.
Cancers Editorial Office
23 July 2024
Cancers | Highly Cited Papers in 2023 in the Section “Systematic Review or Meta-Analysis in Cancer Research”
We are pleased to invite you to read the highly cited papers in 2023 in Cancers (ISSN: 2072-6694) in the Section “Systematic Review or Meta-Analysis in Cancer Research”. The list of relevant papers can be seen below.
“Recruitment and Retention Strategies Used in Dietary Randomized Controlled Interventions with Cancer Survivors: A Systematic Review”
by Samantha J. Werts, Sarah A. Lavelle, Tracy E. Crane and Cynthia A. Thomson
Cancers 2023, 15(20), 5012; https://doi.org/10.3390/cancers15205012
Available online: https://www.mdpi.com/2072-6694/15/17/4366
“Different Outcomes According to Needling Point Location Used in Sham Acupuncture for Cancer-Related Pain: A Systematic Review and Network Meta-Analysis”
by Boram Lee, Chan-Young Kwon, Hye Won Lee, Arya Nielsen, L. Susan Wieland, Tae-Hun Kim, Stephen Birch, Terje Alraek and Myeong Soo Lee
Cancers 2023, 15(24), 5875; https://doi.org/10.3390/cancers15245875
Available online: https://www.mdpi.com/2072-6694/15/24/5875
“Interventions with Social Integration Components Addressing Psychosocial Outcomes of Young- and Middle-Aged Adult Cancer Individuals: A Systematic Review”
by Pragya G. Poudel, Madeline R. Horan, Tara M. Brinkman, Zhaoming Wang, Leslie L. Robison, Melissa M. Hudson and I-Chan Huang
Cancers 2023, 15(19), 4710; https://doi.org/10.3390/cancers15194710
Available online: https://www.mdpi.com/2072-6694/15/19/4710
“The Assessment of White Matter Integrity Alteration Pattern in Patients with Brain Tumor Utilizing Diffusion Tensor Imaging: A Systematic Review”
by Aiman Abdul Manan, Noorazrul Azmie Yahya, Nur Hartini Mohd Taib, Zamzuri Idris and Hanani Abdul Manan
Cancers 2023, 15(13), 3326; https://doi.org/10.3390/cancers15133326
Available online: https://www.mdpi.com/2072-6694/15/13/3326
“Multidimensional Predictors of Cancer-Related Fatigue Based on the Predisposing, Precipitating, and Perpetuating (3P) Model: A Systematic Review”
by Yiming Wang, Lv Tian, Xia Liu, Hao Zhang, Yongchun Tang, Hong Zhang, Wenbo Nie and Lisheng Wang
Cancers 2023, 15(24), 5879; https://doi.org/10.3390/cancers15245879
Available online: https://www.mdpi.com/2072-6694/15/24/5879
“VEGF Inhibitors Improve Survival Outcomes in Patients with Liver Metastases across Cancer Types—A Meta-Analysis”
by Jordan W. Conway, Jorja Braden, Serigne N. Lo, Richard A. Scolyer, Matteo S. Carlino, Alexander M. Menzies, Georgina V. Long and Ines Pires da Silva
Cancers 2023, 15(20), 5012; https://doi.org/10.3390/cancers15205012
Available online: https://www.mdpi.com/2072-6694/15/20/5012
“From Non-Alcoholic Steatohepatitis (NASH) to Hepatocellular Carcinoma (HCC): Epidemiology, Incidence, Predictions, Risk Factors, and Prevention”
by Benedetta Maria Motta, Mario Masarone, Pietro Torre and Marcello Persico
Cancers 2023, 15(22), 5458; https://doi.org/10.3390/cancers15225458
Available online: https://www.mdpi.com/2072-6694/15/22/5458
“Treatment and Outcomes of Radiation-Induced Soft Tissue Sarcomas of the Extremities and Trunk—A Systematic Review of the Literature”
by Maria L. Inchaustegui, Kelly Kon-Liao, Kim Ruiz-Arellanos, George Aquilino E. Silva, Marcos R. Gonzalez and Juan Pretell-Mazzini
Cancers 2023, 15(23), 5584; https://doi.org/10.3390/cancers15235584
Available online: https://www.mdpi.com/2072-6694/15/23/5584
You are invited to view and submit relevant papers to the journal Cancers.
Cancers Editorial Office
19 July 2024
Cancers | Highly Cited Papers in 2023 in the Section “Cancer Epidemiology and Prevention”
As all of the articles published in Cancers (ISSN: 2072-6694) are open access, you have free and unlimited access to the full text of all articles. We welcome you to read our most highly cited papers published in 2023 in the Section “Cancer Epidemiology and Prevention”, which are listed below:
1. “The Evolution of Ki-67 and Breast Carcinoma: Past Observations, Present Directions, and Future Considerations”
by Brian S. Finkelman, Huina Zhang, David G. Hicks and Bradley M. Turner
Cancers 2023, 15(3), 808; https://doi.org/10.3390/cancers15030808
Available online: https://www.mdpi.com/2072-6694/15/3/808
2. “Polybrominated Diphenyl Ethers (PBDEs) and Human Health: Effects on Metabolism, Diabetes and Cancer”
by Valerio Renzelli, Marco Gallo, Lelio Morviducci, Giampiero Marino, Alberto Ragni, Enzo Tuveri, Antongiulio Faggiano, Rossella Mazzilli, Annalisa Natalicchio, Maria Chiara Zatelli et al.
Cancers 2023, 15(17), 4237; https://doi.org/10.3390/cancers15174237
Available online: https://www.mdpi.com/2072-6694/15/17/4237
3. “Squamous Cell Carcinoma of the Oral Cavity, Oropharynx, and Larynx: A Scoping Review of Treatment Guidelines Worldwide”
by Lady Paola Aristizabal Arboleda, Genival Barbosa de Carvalho, Alan Roger Santos-Silva, Gisele Aparecida Fernandes, Jose Guilherme Vartanian, David I. Conway, Shama Virani, Paul Brennan, Luiz Paulo Kowalski and Maria Paula Curado
Cancers 2023, 15(17), 4405; https://doi.org/10.3390/cancers15174405
Available online: https://www.mdpi.com/2072-6694/15/17/4405
4. “Temporal Machine Learning Analysis of Prior Mammograms for Breast Cancer Risk Prediction”
by Hui Li, Kayla Robinson, Li Lan, Natalie Baughan, Chun-Wai Chan, Matthew Embury, Gary J. Whitman, Randa El-Zein, Isabelle Bedrosian and Maryellen L. Giger
Cancers 2023, 15(7), 2141; https://doi.org/10.3390/cancers15072141
Available online: https://www.mdpi.com/2072-6694/15/7/2141
5. “Traffic-Related Air Pollution and Breast Cancer Risk: A Systematic Review and Meta-Analysis of Observational Studies”
by Delphine Praud, Floriane Deygas, Amina Amadou, Maryline Bouilly, Federica Turati, Francesca Bravi, Tingting Xu, Lény Grassot, Thomas Coudon and Béatrice Fervers
Cancers 2023, 15(3), 927; https://doi.org/10.3390/cancers15030927
Available online: https://www.mdpi.com/2072-6694/15/3/927
6. “Systemic Inflammation Indices and Association with Prostate Cancer Survival in a Diverse Patient Cohort”
by Maeve Bailey-Whyte, Tsion Z. Minas, Tiffany H. Dorsey, Cheryl J. Smith, Christopher A. Loffredo and Stefan Ambs
Cancers 2023, 15(6), 1869; https://doi.org/10.3390/cancers15061869
Available online: https://www.mdpi.com/2072-6694/15/6/1869
7. “The Promise of Piperine in Cancer Chemoprevention”
by Salma Benayad, Hicham Wahnou, Riad El Kebbaj, Bertrand Liagre, Vincent Sol, Mounia Oudghiri, El Madani Saad, Raphaël Emmanuel Duval and Youness Limami
Cancers 2023, 15(22), 5488; https://doi.org/10.3390/cancers15225488
Available online: https://www.mdpi.com/2072-6694/15/22/5488
8. “Health-Related Quality of Life as Assessed by the EQ-5D-5L Predicts Outcomes of Patients Treated with Azacitidine—A Prospective Cohort Study by the AGMT”
by Lisa Pleyer, Sonja Heibl, Christoph Tinchon, Sonia Vallet, Martin Schreder, Thomas Melchardt, Norbert Stute, Kim Tamara Föhrenbach Quiroz, Michael Leisch, Alexander Egle et al.
Cancers 2023, 15(5), 1388; https://doi.org/10.3390/cancers15051388
Available online: https://www.mdpi.com/2072-6694/15/5/1388
9. “Rising Trend in the Prevalence of HPV-Driven Oropharyngeal Squamous Cell Carcinoma during 2000–2022 in Northeastern Italy: Implication for Using p16INK4a as a Surrogate Marker for HPV-Driven Carcinogenesis”
by Paolo Boscolo-Rizzo, Jerry Polesel, Annarosa Del Mistro, Elisabetta Fratta, Chiara Lazzarin, Anna Menegaldo, Valentina Lupato, Giuseppe Fanetti, Fabrizio Zanconati, Maria Guido et al.
Cancers 2023, 15(9), 2643; https://doi.org/10.3390/cancers15092643
Available online: https://www.mdpi.com/2072-6694/15/9/2643
10. “Risk of Oral Squamous Cell Carcinoma in One Hundred Patients with Oral Lichen Planus: A Follow-Up Study of Umberto I University Hospital of Rome”
by Gianluca Tenore, Ahmed Mohsen, Federica Rocchetti, Giulia Rossi, Andrea Cassoni, Andrea Battisti, Marco Della Monaca, Cira Rosaria Tiziana Di Gioia, Francesca De Felice, Andrea Botticelli et al.
Cancers 2023, 15(11), 3004; https://doi.org/10.3390/cancers15113004
Available online: https://www.mdpi.com/2072-6694/15/11/3004
11. “Melanoma Mortality Trends in 28 European Countries: A Retrospective Analysis for the Years 1960–2020”
by Paweł Koczkodaj, Urszula Sulkowska, Joanna Didkowska, Piotr Rutkowski and Marta Mańczuk
Cancers 2023, 15(5), 1514; https://doi.org/10.3390/cancers15051514
Available online: https://www.mdpi.com/2072-6694/15/5/1514
12. “Development of Symbolic Expressions Ensemble for Breast Cancer Type Classification Using Genetic Programming Symbolic Classifier and Decision Tree Classifier”
by Nikola Anđelić and Sandi Baressi Šegota
Cancers 2023, 15(13), 3411; https://doi.org/10.3390/cancers15133411
Available online: https://www.mdpi.com/2072-6694/15/13/3411
13. “Combining Breast Cancer Risk Prediction Models”
by Zoe Guan, Theodore Huang, Anne Marie McCarthy, Kevin Hughes, Alan Semine, Hajime Uno, Lorenzo Trippa, Giovanni Parmigiani and Danielle Braun
Cancers 2023, 15(4), 1090; https://doi.org/10.3390/cancers15041090
Available online: https://www.mdpi.com/2072-6694/15/4/1090
14. “Association between Prior Cytotoxic Therapy, Antecedent Hematologic Disorder, and Outcome after Allogeneic Hematopoietic Cell Transplantation in Adult Acute Myeloid Leukemia”
by Corentin Orvain, Eduardo Rodríguez-Arbolí, Megan Othus, Brenda M. Sandmaier, H. Joachim Deeg, Frederick R. and Roland B. Walter
Cancers 2023, 15(2), 352; https://doi.org/10.3390/cancers15020352
Available online: https://www.mdpi.com/2072-6694/15/2/352
15. “Lack of Influence of Non-Overlapping Mutations in BRAF, NRAS, or NF1 on 12-Month Best Objective Response and Long-Term Survival after Checkpoint Inhibitor-Based Treatment for Metastatic Melanoma”
by Alyssa Panning, Wolfram Samlowski and Gabriel Allred
Cancers 2023, 15(13), 3572; https://doi.org/10.3390/cancers15133527
Available online: https://www.mdpi.com/2072-6694/15/13/3527
You are invited to view and submit relevant papers to the journal Cancers.
Cancers Editorial Office
18 July 2024
Cancers | Highly Cited Papers in 2023 in the Section “Cancer Biomarkers”
As all of the articles published in Cancers (ISSN: 2072-6694) are open access, you have free and unlimited access to the full text of all articles. We welcome you to read our most highly cited papers published in 2023 in the Section “Cancer Biomarkers”, which are listed below:
1. “Advances in Genomic Data and Biomarkers: Revolutionizing NSCLC Diagnosis and Treatment”
by Juan Carlos Restrepo, Diana Dueñas, Zuray Corredor and Yamil Liscano
Cancers 2023, 15(13), 3474; https://doi.org/10.3390/cancers15133474
Available online: https://www.mdpi.com/2072-6694/15/13/3474
2. “Performance of Node-RADS Scoring System for a Standardized Assessment of Regional Lymph Nodes in Bladder Cancer Patients”
by Costantino Leonardo, Rocco Simone Flammia, Sara Lucciola, Flavia Proietti, Martina Pecoraro, Bruno Bucca, Leslie Claire Licari, Antonella Borrelli, Eugenio Bologna, Nicholas Landini et al.
Cancers 2023, 15(3), 580; https://doi.org/10.3390/cancers15030580
Available online: https://www.mdpi.com/2072-6694/15/3/580
3. “Emerging Biosensing Methods to Monitor Lung Cancer Biomarkers in Biological Samples: A Comprehensive Review”
by Raja Chinnappan, Tanveer Ahmad Mir, Sulaiman Alsalameh, Tariq Makhzoum, Alaa Alzhrani, Khalid Alnajjar, Salma Adeeb, Noor Al Eman, Zara Ahmed, Ismail Shakir et al.
Cancers 2023, 15(13), 3414; https://doi.org/10.3390/cancers15133414
Available online: https://www.mdpi.com/2072-6694/15/13/3414
4. “PET/CT with Fibroblast Activation Protein Inhibitors in Breast Cancer: Diagnostic and Theranostic Application—A Literature Review”
by Silvia Taralli, Margherita Lorusso, Elisabetta Perrone, Germano Perotti, Luca Zagaria and Maria Lucia Calcagni
Cancers 2023, 15(3), 908; https://doi.org/10.3390/cancers15030908
Available online: https://www.mdpi.com/2072-6694/15/3/908
5. “Discordance of HER2-Low between Primary Tumors and Matched Distant Metastases in Breast Cancer”
by Katrin Almstedt, Lisa Krauthauser, Franziska Kappenberg, Daniel-Christoph Wagner, Anne-Sophie Heimes, Marco J. Battista, Katharina Anic, Slavomir Krajnak, Antje Lebrecht, Roxana Schwab et al.
Cancers 2023, 15(5), 1413; https://doi.org/10.3390/cancers15051413
Available online: https://www.mdpi.com/2072-6694/15/5/1413
6. “LncRNA HCP5-Encoded Protein Regulates Ferroptosis to Promote the Progression of Triple-Negative Breast Cancer”
by Xiao Tong, Zhengling Yu, Jiani Xing, Haizhou Liu, Shunheng Zhou, Yu’e Huang, Jing Lin, Wei Jiang and Lihong Wang
Cancers 2023, 15(6), 1880; https://doi.org/10.3390/cancers15061880
Available online: https://www.mdpi.com/2072-6694/15/6/1880
7. “Clinical and Histopathological Features of an Italian Monocentric Series of Primary Small Bowel T-Cell Lymphomas”
by Marco Lucioni, Sara Fraticelli, Giovanni Santacroce, Arturo Bonometti, Nicola Aronico, Roberta Sciarra, Marco Vincenzo Lenti, Paola Ilaria Bianchi, Giuseppe Neri, Monica Feltri et al.
Cancers 2023, 15(10), 2743; https://doi.org/10.3390/cancers15102743
Available online: https://www.mdpi.com/2072-6694/15/10/2743
8. “Emerging Role of IGF-1 in Prostate Cancer: A Promising Biomarker and Therapeutic Target”
by Guoqiang Liu, Minggang Zhu, Mingrui Zhang and Feng Pan
Cancers 2023, 15(4), 1287; https://doi.org/10.3390/cancers15041287
Available online: https://www.mdpi.com/2072-6694/15/4/1287
9. “Body Composition of Patients Undergoing Radical Cystectomy for Bladder Cancer: Sarcopenia, Low Psoas Muscle Index, and Myosteatosis Are Independent Risk Factors for Mortality”
by Simon U. Engelmann, Christoph Pickl, Maximilian Haas, Sebastian Kaelble, Valerie Hartmann, Maximilian Firsching, Laura Lehmann, Miodrag Gužvić, Bas W. G. van Rhijn, Johannes Breyer et al.
Cancers 2023, 15(6), 1778; https://doi.org/10.3390/cancers15061778
Available online: https://www.mdpi.com/2072-6694/15/6/1778
10. “The Antithetic Roles of IQGAP2 and IQGAP3 in Cancers”
by Fei Song, Qingqing Dai, Marc-Oliver Grimm and Daniel Steinbach
Cancers 2023, 15(4), 1115; https://doi.org/10.3390/cancers15041115
Available online: https://www.mdpi.com/2072-6694/15/4/1115
11. “Unlocking the Potential of Circulating miRNAs in the Breast Cancer Neoadjuvant Setting: A Systematic Review and Meta-Analysis”
by Paola Tiberio, Mariangela Gaudio, Silvia Belloni, Sebastiano Pindilli, Chiara Benvenuti, Flavia Jacobs, Giuseppe Saltalamacchia, Alberto Zambelli, Armando Santoro and Rita De Sanctis
Cancers 2023, 15(13), 3424; https://doi.org/10.3390/cancers15133424
Available online: https://www.mdpi.com/2072-6694/15/13/3424
12. “Assessment of Barriers and Challenges to Screening, Diagnosis, and Biomarker Testing in Early-Stage Lung Cancer”
by Reza Zarinshenas, Arya Amini, Isa Mambetsariev, Tariq Abuali, Jeremy Fricke, Colton Ladbury and Ravi Salgia
Cancers 2023, 15(5), 1595; https://doi.org/10.3390/cancers15051595
Available online: https://www.mdpi.com/2072-6694/15/5/1595
13. “RBM15 Promates the Proliferation, Migration and Invasion of Pancreatic Cancer Cell Lines”
by Hui Dong, Haidong Zhang, Xinyu Mao, Shiwei Liu, Wenjing Xu and Yewei Zhang
Cancers 2023, 15(4), 1084; https://doi.org/10.3390/cancers15041084
Available online: https://www.mdpi.com/2072-6694/15/4/1084
14. “The Importance of Detecting, Quantifying, and Characterizing Exosomes as a New Diagnostic/Prognostic Approach for Tumor Patients”
by Mariantonia Logozzi, Nicola Salvatore Orefice, Rossella Di Raimo, Davide Mizzoni and Stefano Fais
Cancers 2023, 15(11), 2878; https://doi.org/10.3390/cancers15112878
Available online: https://www.mdpi.com/2072-6694/15/11/2878
15. “Accurate Detection of Urothelial Bladder Cancer Using Targeted Deep Sequencing of Urine DNA”
by Dongin Lee, Wookjae Lee, Hwang-Phill Kim, Myong Kim, Hyun Kyu Ahn, Duhee Bang and Kwang Hyun Kim
Cancers 2023, 15(10), 2868; https://doi.org/10.3390/cancers15102868
Available online: https://www.mdpi.com/2072-6694/15/10/2868
You are invited to view and submit relevant papers to the journal Cancers.
Cancers Editorial Office
18 July 2024
Cancers | Highly Cited Papers in 2023 in the Section “Cancer Causes, Screening and Diagnosis”
As all of the articles published in Cancers (ISSN: 2072-6694) are open access, you have free and unlimited access to the full text of all articles. We welcome you to read our most highly cited papers published in 2023 in the Section “Cancer Causes, Screening and Diagnosis”, which are listed below:
1. “Deep Learning in Different Ultrasound Methods for Breast Cancer, from Diagnosis to Prognosis: Current Trends, Challenges, and an Analysis”
by Humayra Afrin, Nicholas B. Larson, Mostafa Fatemi and Azra Alizad
Cancers 2023, 15(12), 3139; https://doi.org/10.3390/cancers15123139
Available online: https://www.mdpi.com/2072-6694/15/12/3139
2. “Multi-Method Analysis of Histopathological Image for Early Diagnosis of Oral Squamous Cell Carcinoma Using Deep Learning and Hybrid Techniques”
by Mehran Ahmad, Muhammad Abeer Irfan, Umar Sadique, Ihtisham ul Haq, Atif Jan, Muhammad Irfan Khattak, Yazeed Yasin Ghadi and Hanan Aljuaid
Cancers 2023, 15(21), 5247; https://doi.org/10.3390/cancers15215247
Available online: https://www.mdpi.com/2072-6694/15/21/5247
3. “Molecular Theranostics in Radioiodine-Refractory Differentiated Thyroid Cancer”
by Petra Petranović Ovčariček, Alfredo Campenni, Bart de Keizer, Desiree Deandreis, Michael C. Kreissl, Alexis Vrachimis, Murat Tuncel and Luca Giovanella
Cancers 2023, 15(17), 4290; https://doi.org/10.3390/cancers15174290
Available online: https://www.mdpi.com/2072-6694/15/17/4290
4. “AI-Assisted Screening of Oral Potentially Malignant Disorders Using Smartphone-Based Photographic Images”
by Vivek Talwar, Pragya Singh, Nirza Mukhia, Anupama Shetty, Praveen Birur, Karishma M. Desai, Chinnababu Sunkavalli, Konala S. Varma, Ramanathan Sethuraman, C. V. Jawahar et al.
Cancers 2023, 15(16), 4120; https://doi.org/10.3390/cancers15164120
Available online: https://www.mdpi.com/2072-6694/15/16/4120
5. “Human Papillomavirus-Associated Oropharyngeal Cancer: Global Epidemiology and Public Policy Implications”
by Sifon Ndon, Amritpal Singh, Patrick K. Ha, Joyce Aswani, Jason Ying-Kuen Chan and Mary Jue Xu
Cancers 2023, 15(16), 4080; https://doi.org/10.3390/cancers15164080
Available online: https://www.mdpi.com/2072-6694/15/16/4080
6. “The Role of Staging Laparoscopy for Gastric Cancer Patients: Current Evidence and Future Perspectives”
by Carlo Alberto Schena, Vito Laterza, Davide De Sio, Giuseppe Quero, Claudio Fiorillo, Gayani Gunawardena, Antonia Strippoli, Vincenzo Tondolo, Nicola de’Angelis, Sergio Alfieri et al.
Cancers 2023, 15(13), 3425; https://doi.org/10.3390/cancers15133425
Available online: https://www.mdpi.com/2072-6694/15/13/3425
7. “Stromal POSTN Enhances Motility of Both Cancer and Stromal Cells and Predicts Poor Survival in Colorectal Cancer”
by Akane Ueki, Masayuki Komura, Akira Koshino, Chengbo Wang, Kazuhiro Nagao, Mai Homochi, Yuki Tsukada, Masahide Ebi, Naotaka Ogasawara, Toyonori Tsuzuki et al.
Cancers 2023, 15(3), 606; https://doi.org/10.3390/cancers15030606
Available online: https://www.mdpi.com/2072-6694/15/3/606
8. “Clinical-Radiomics Nomogram Based on Contrast-Enhanced Ultrasound for Preoperative Prediction of Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma”
by Liqing Jiang, Zijian Zhang, Shiyan Guo, Yongfeng Zhao and Ping Zhou
Cancers 2023, 15(5), 1613; https://doi.org/10.3390/cancers15051613
Available online: https://www.mdpi.com/2072-6694/15/5/1613
9. “Analysis of Artificial Intelligence-Based Approaches Applied to Non-Invasive Imaging for Early Detection of Melanoma: A Systematic Review”
by Raj H. Patel, Emilie A. Foltz, Alexander Witkowski and Joanna Ludzik
Cancers 2023, 15(19), 4694; https://doi.org/10.3390/cancers15194694
Available online: https://www.mdpi.com/2072-6694/15/19/4694
10. “A Handheld Visible Resonance Raman Analyzer Used in Intraoperative Detection of Human Glioma”
by Liang Zhang, Yan Zhou, Binlin Wu, Shengjia Zhang, Ke Zhu, Cheng-Hui Liu, Xinguang Yu and Robert R. Alfano
Cancers 2023, 15(6), 1752; https://doi.org/10.3390/cancers15061752
Available online: https://www.mdpi.com/2072-6694/15/6/1752
11. “Diagnosis and Treatment of Peripheral and Cranial Nerve Tumors with Expert Recommendations: An EUropean Network for RAre CANcers (EURACAN) Initiative”
by Alessia Pellerino, Robert M. Verdijk, Lucia Nichelli, Nicolaus H. Andratschke, Ahmed Idbaih and Roland Goldbrunner
Cancers 2023, 15(7), 1930; https://doi.org/10.3390/cancers15071930
Available online: https://www.mdpi.com/2072-6694/15/7/1930
12. “Evaluating the Potential of Delta Radiomics for Assessing Tyrosine Kinase Inhibitor Treatment Response in Non-Small Cell Lung Cancer Patients”
by Ting-Wei Wang, Heng-Sheng Chao, Hwa-Yen Chiu, Yi-Hui Lin, Hung-Chun Chen, Chia-Feng Lu, Chien-Yi Liao, Yen Lee, Tsu-Hui Shiao, Yuh-Min Chen et al.
Cancers 2023, 15(21), 5125; https://doi.org/10.3390/cancers15215125
Available online: https://www.mdpi.com/2072-6694/15/21/5125
13. “A Hybrid Algorithm of ML and XAI to Prevent Breast Cancer: A Strategy to Support Decision Making”
by Fabián Silva-Aravena, Hugo Núñez Delafuente, Jimmy H. Gutiérrez-Bahamondes and Jenny Morales
Cancers 2023, 15(9), 2443; https://doi.org/10.3390/cancers15092443
Available online: https://www.mdpi.com/2072-6694/15/9/2443
14. “SAINT: A Phase I/Expanded Phase II Study Using Safe Amounts of Ipilimumab, Nivolumab and Trabectedin as First-Line Treatment of Advanced Soft Tissue Sarcoma”
by Erlinda Maria Gordon, Sant P. Chawla, Walter Andree Tellez, Elan Younesi, Sonu Thomas, Victoria S. Chua-Alcala, Hripsime Chomoyan, Chrysler Valencia, Don Arlen Brigham, Ania Moradkhani et al.
Cancers 2023, 15(3), 906; https://doi.org/10.3390/cancers15030906
Available online: https://www.mdpi.com/2072-6694/15/3/906
15. “Improving Prediction of Cervical Cancer Using KNN Imputed SMOTE Features and Multi-Model Ensemble Learning Approach”
by Hanen Karamti, Raed Alharthi, Amira Al Anizi, Reemah M. Alhebshi, Ala’ Abdulmajid Eshmawi, Shtwai Alsubai and Muhammad Umer
Cancers 2023, 15(17), 4412; https://doi.org/10.3390/cancers15174412
Available online: https://www.mdpi.com/2072-6694/15/17/4412
You are invited to view and submit relevant papers to the journal Cancers.
Cancers Editorial Office
18 July 2024
Cancers | Highly Cited Papers in 2023 in the Section “Cancer Survivorship and Quality of Life”
As all of the articles published in Cancers (ISSN: 2072-6694) are open access, you have free and unlimited access to the full text of all articles. We welcome you to read our most highly cited papers published in 2023 in the Section “Cancer Survivorship and Quality of Life”, which are listed below:
1. “Depression, Inflammation, and Intestinal Permeability: Associations with Subjective and Objective Cognitive Functioning throughout Breast Cancer Survivorship”
by Annelise A. Madison, Rebecca Andridge, Anthony H. Kantaras, Megan E. Renna, Jeanette M. Bennett, Catherine M. Alfano, Stephen P. Povoski, Doreen M. Agnese, Maryam Lustberg, Robert Wesolowski et al.
Cancers 2023, 15(17), 4414; https://doi.org/10.3390/cancers15174414
Available online: https://www.mdpi.com/2072-6694/15/17/4414
2. “First-Line Immunotherapy with Check-Point Inhibitors: Prospective Assessment of Cognitive Function”
by Jamie S. Myers, Adam C. Parks, Jonathan D. Mahnken, Kate J. Young, Harsh B. Pathak, Rajni V. Puri, Amber Unrein, Phyllis Switzer, Yazan Abdulateef, Samantha Sullivan et al.
Cancers 2023, 15(5), 1615; https://doi.org/10.3390/cancers15051615
Available online: https://www.mdpi.com/2072-6694/15/5/1615
3. “Characteristics and Components of Self-Management Interventions for Improving Quality of Life in Cancer Survivors: A Systematic Review”
by Ben Rimmer, Morven C. Brown, Tumi Sotire, Fiona Beyer, Iakov Bolnykh, Michelle Balla, Catherine Richmond, Lizzie Dutton, Sophie Williams, Vera Araújo-Soares et al.
Cancers 2024, 16(1), 14; https://doi.org/10.3390/cancers16010014
Available online: https://www.mdpi.com/2072-6694/16/1/14
4. “The Association between the Gut Microbiome and Development and Progression of Cancer Treatment Adverse Effects”
by Amanda S. Maddern, Janet K. Coller, Joanne M. Bowen and Rachel J. Gibson
Cancers 2023, 15(17), 4301; https://doi.org/10.3390/cancers15174301
Available online: https://www.mdpi.com/2072-6694/15/17/4301
5. “The Role of Exercise in Cancer-Related Sarcopenia and Sarcopenic Obesity”
by Argyro Papadopetraki, Antonios Giannopoulos, Maria Maridaki, Flora Zagouri, Stavroula Droufakou, Michael Koutsilieris and Anastassios Philippou
Cancers 2023, 15(24), 5856; https://doi.org/10.3390/cancers15245856
Available online: https://www.mdpi.com/2072-6694/15/24/5856
6. “Preoperative CT-Based Skeletal Muscle Mass Depletion and Outcomes after Total Laryngectomy”
by Victoria Salati, Katerina Mandralis, Fabio Becce, Joachim Koerfer, Karma Lambercy, Christian Simon and François Gorostidi
Cancers 2023, 15(14), 3538; https://doi.org/10.3390/cancers15143538
Available online: https://www.mdpi.com/2072-6694/15/14/3538
7. “Consumer Perspectives on the Adoption of a Prehabilitation Multimodal Online Program for Patients Undergoing Cancer Surgery”
by Daniel Steffens, Linda Denehy, Michael Solomon, Cherry Koh, Nabila Ansari, Kate McBride, Sharon Carey, Jenna Bartyn, Aaron Sean Lawrence, Kym Sheehan et al.
Cancers 2023, 15(20), 5039; https://doi.org/10.3390/cancers15205039
Available online: https://www.mdpi.com/2072-6694/15/20/5039
8. “A Novel Score Using Lymphocyte-to-Monocyte Ratio in Blood and Malignant Body Fluid for Predicting Prognosis of Patients with Advanced Ovarian Cancer”
by Min Jin Jeong, Yeo Nyeong Yoon, Yeon Kyung Kang, Chan Joo Kim, Hae Seong Nam and Yong Seok Lee
Cancers 2023, 15(8), 2328; https://doi.org/10.3390/cancers15082328
Available online: https://www.mdpi.com/2072-6694/15/8/2328
9. “Assessing the Needs of Those Who Serve the Underserved: A Qualitative Study among US Oncology Clinicians”
by Manali I. Patel, Leslie Hinyard, Fay J. Hlubocky, Janette K. Merrill, Kimberly T. Smith, Sailaja Kamaraju, Daniel Carrizosa, Tricia Kalwar, Lola Fashoyin-Aje, Scarlett L. Gomez et al.
Cancers 2023, 15(13), 3311; https://doi.org/10.3390/cancers15133311
Available online: https://www.mdpi.com/2072-6694/15/13/3311
10. “Patient-Reported Mobility, Physical Activity, and Bicycle Use after Vulvar Carcinoma Surgery”
by Nick J. van de Berg, Franciscus P. van Beurden, G. C. Wanda Wendel-Vos, Marjolein Duijvestijn, Heleen J. van Beekhuizen, Marianne Maliepaard and Helena C. van Doorn
Cancers 2023, 15(8), 2324; https://doi.org/10.3390/cancers15082324
Available online: https://www.mdpi.com/2072-6694/15/8/2324
11. “Colorectal Cancer Surgery: Influence of Psychosocial Factors”
by Regina Moldes-Moro and María José de Dios-Duarte
Cancers 2023, 15(16), 4140; https://doi.org/10.3390/cancers15164140
Available online: https://www.mdpi.com/2072-6694/15/16/4140
12. “Complications of Central Venous Access Devices Used in Palliative Care Settings for Terminally Ill Cancer Patients: A Systematic Review and Meta-Analysis”
by Clement Chun-Him Wong, Horace Cheuk-Wai Choi and Victor Ho-Fun Lee
Cancers 2023, 15(19), 4712; https://doi.org/10.3390/cancers15194712
Available online: https://www.mdpi.com/2072-6694/15/19/4712
13. “Predicting Long-Term Care Service Demands for Cancer Patients: A Machine Learning Approach”
by Shuo-Chen Chien, Yu-Hung Chang, Chia-Ming Yen, Ying-Erh Chen, Chia-Chun Liu, Yu-Ping Hsiao, Ping-Yen Yang, Hong-Ming Lin, Xing-Hua Lu, I-Chien Wu et al.
Cancers 2023, 15(18), 4598; https://doi.org/10.3390/cancers15184598
Available online: https://www.mdpi.com/2072-6694/15/18/4598
14. “Treatment of Colorectal Cancer in Certified Centers: Results of a Large German Registry Study Focusing on Long-Term Survival”
by Vinzenz Völkel, Michael Gerken, Kees Kleihues-van Tol, Olaf Schoffer, Veronika Bierbaum, Christoph Bobeth, Martin Roessler, Christoph Reissfelder, Alois Fürst, Stefan Benz et al.
Cancers 2023, 15(18), 4568; https://doi.org/10.3390/cancers15184568
Available online: https://www.mdpi.com/2072-6694/15/18/4568
15. “Immunotherapy-Related Oral Adverse Effects: Immediate Sequelae, Chronicity and Secondary Cancer”
by Sharon Elad, Noam Yarom and Yehuda Zadik
Cancers 2023, 15(19), 4781; https://doi.org/10.3390/cancers15194781
Available online: https://www.mdpi.com/2072-6694/15/19/4781
You are invited to view and submit relevant papers to the journal Cancers.
Cancers Editorial Office
